Literature DB >> 9022006

Regulated production of the interferon-gamma-inducible protein-10 (IP-10) chemokine by human neutrophils.

M A Cassatella1, S Gasperini, F Calzetti, A Bertagnin, A D Luster, P P McDonald.   

Abstract

Interferon-gamma (IFN-gamma)-inducible protein-10 (IP-10), a member of the C-X-C sub-family of chemokines, is known to be produced by monocytes, lymphocytes, keratinocytes and endothelial cells in response to IFN-gamma. Here, we show that human polymorphonuclear neutrophils (PMN) also have the ability to produce IP-10. IFN-gamma alone had a modest effect on IP-10 mRNA accumulation, whereas tumor necrosis factor-alpha (TNF-alpha), yeast particles opsonized with IgG (Y-IgG), lipopolysaccharide (LPS), and formyl-methionyl-leucyl-phenylalanine (fMLP) all failed to up-regulate IP-10 gene expression. However, stimulation of neutrophils with IFN-gamma in combination with either TNF-alpha or LPS (but not with Y-IgG or fMLP) resulted in a considerable induction of IP-10 mRNA transcripts, as well as in the extracellular release of the protein. In contrast, the best inducer of IP-10 release from peripheral blood mononuclear cells was IFN-gamma alone. Furthermore, mRNA stabilization analyses demonstrated that IP-10 mRNA isolated from PMN stimulated with IFN-gamma only, or with IFN-gamma plus either TNF-alpha or LPS, had similar half-lives. Finally, we found that interleukin-10, a known inhibitor of chemokine production in PMN, moderately suppressed the extracellular production of IP-10 in neutrophils stimulated with IFN-gamma plus either LPS or TNF-alpha. Since IP-10 is a potent chemoattractant for activated T lymphocytes, the ability of neutrophils to produce IP-10 might contribute to the evolution and progression of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9022006     DOI: 10.1002/eji.1830270117

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  46 in total

1.  Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.

Authors:  Akira Hachiya; Norimoto Kobayashi; Satoshi Matsuzaki; Yusuke Takeuchi; Yohei Akazawa; Tomonari Shigemura; Noriko Motoki; Junya Masumoto; Kazunaga Agematsu
Journal:  Clin Rheumatol       Date:  2018-01-04       Impact factor: 2.980

2.  Roles for tumor necrosis factor and gamma interferon in resistance to enteric listeriosis.

Authors:  G R Beretich; P B Carter; E A Havell
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Changes of serum cytokine profiles in Korean vivax malarial patients after chemotherapy.

Authors:  T S Kim; Y B Chung; H J Choi; H J Yang
Journal:  Parasitol Res       Date:  2006-07-11       Impact factor: 2.289

4.  Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells.

Authors:  Danielle D Kish; Nina Volokh; William M Baldwin; Robert L Fairchild
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

5.  CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin.

Authors:  Akihiko Ichikawa; Keiji Kuba; Masayuki Morita; Shinsuke Chida; Hiroyuki Tezuka; Hiromitsu Hara; Takehiko Sasaki; Toshiaki Ohteki; V Marco Ranieri; Claudia C dos Santos; Yoshihiro Kawaoka; Shizuo Akira; Andrew D Luster; Bao Lu; Josef M Penninger; Stefan Uhlig; Arthur S Slutsky; Yumiko Imai
Journal:  Am J Respir Crit Care Med       Date:  2012-11-09       Impact factor: 21.405

6.  Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation.

Authors:  B Qiu; K A Frait; F Reich; E Komuniecki; S W Chensue
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

7.  Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Offer Erez; Nandor Gabor Than; Samuel Edwin; Moshe Mazor; Bo Hyan Yoon; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-10

8.  Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes.

Authors:  Rachel Williams; Navneet K Dhillon; Sonia T Hegde; Honghong Yao; Fuwang Peng; Shannon Callen; Yahia Chebloune; Randall L Davis; Shilpa J Buch
Journal:  Glia       Date:  2009-05       Impact factor: 7.452

9.  Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.

Authors:  Jennifer K Quint; Gavin C Donaldson; James J P Goldring; Ramin Baghai-Ravary; John R Hurst; Jadwiga A Wedzicha
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

10.  Production of macrophage inflammatory protein 3alpha (MIP-3alpha) (CCL20) and MIP-3beta (CCL19) by human peripheral blood neutrophils in response to microbial pathogens.

Authors:  Tohru Akahoshi; Takeshi Sasahara; Rie Namai; Toshimichi Matsui; Hiroyuki Watabe; Hidero Kitasato; Matsuhisa Inoue; Hirobumi Kondo
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.